Associated tags: Hospital, RCM, Reliability-centered maintenance, News
Locations: CANADA, UNITED STATES, PHILIPPINES, CHICAGO, IL, US, UTAH, INDIA
MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook.
Key Points:
- MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook.
- The quarter reflects impacts of the Change Healthcare cyberattack totaling $9.5 million for revenue and adjusted EBITDA as well as additional impact from a modular customer bankruptcy.
- “First quarter results reflect the strength and flexibility of our technology platform, our people, and our global scale.
- R1’s management team will host a conference call today at 8:00 a.m. Eastern Time to discuss the Company’s financial results and business outlook.
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m.
Key Points:
- MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m.
- ET to review the results.
- Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341.
- A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at r1rcm.com.
Retrieved on:
Wednesday, March 27, 2024
Health,
Annual report,
Culture,
Organization,
Intermountain,
Human Rights Campaign,
ESG,
Patient,
RCM,
Form 10-K,
Bank statement,
Social,
Reliability-centered maintenance,
Tree,
Workplace,
U.N,
Management MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report .
Key Points:
- MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report .
- The report details the company’s commitment to improving access to healthcare, bringing responsible global citizenship to life through its ESG program.
- R1 does not undertake to update its forward-looking statements except to the extent required by applicable law.
- All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements.
MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C.
Key Points:
- MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C.
- Consistent with its fiduciary duties, and in consultation with its independent advisors, the Special Committee will carefully review the communications from New Mountain Capital and evaluate strategic alternatives to determine the course of action that it believes is in the best interests of R1 and its stockholders.
- R1 remains focused on providing clients with world-class revenue cycle solutions to help providers improve their financial performance and deliver an exceptional patient experience.
- No assurances can be given regarding the outcome or timing of the Special Committee’s review process.
Retrieved on:
Tuesday, February 27, 2024
Acquisition,
Hospital,
Depreciation,
Forecasting,
Form 10-K,
RCM,
Growth,
Annual report,
Capital expenditure,
GAAP,
Bank statement,
Reliability-centered maintenance,
Bank MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023.
Key Points:
- MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023.
- Our strategy is to leverage our best-in-class capabilities to deploy flexible models that meet customers where they are in their revenue cycle journey.
- R1’s management team will host a conference call today at 8:00 a.m. Eastern Time to discuss its financial results and business outlook.
- Subsequent events and developments, including actual results or changes in the Company’s assumptions, may cause the Company’s views to change.
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).
Key Points:
- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).
- Investors who purchased R1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCM .
- You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
- Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.
Retrieved on:
Wednesday, February 28, 2024
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).
Key Points:
- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).
- Investors who purchased R1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCM .
- You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
- Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.
Retrieved on:
Friday, February 16, 2024
MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences:
Key Points:
- MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences:
The 2024 TD Cowen Healthcare Conference on Monday, March 4 at 10:30am ET
The 2024 Barclays Global Healthcare Conference on Wednesday, March 13 at 4:35pm ET
A live audio webcast of each presentation will be available on the Investor Relations section of R1’s website at r1rcm.com .
- A replay of the webcast will be available for 90 days following the live webcast.
Retrieved on:
Wednesday, February 7, 2024
Now an 11-time Best in KLAS winner, R1 also earned top rankings this year for Government Reimbursement Services and Underpayment Recovery Services, the first and third time winning in these categories, respectively.
Key Points:
- Now an 11-time Best in KLAS winner, R1 also earned top rankings this year for Government Reimbursement Services and Underpayment Recovery Services, the first and third time winning in these categories, respectively.
- “Healthcare providers need us now more than ever, and we are committed to meeting them where they are and helping them on their journey.
- R1’s ability to integrate across multiple EHR's, maximize earned reimbursement for Medicare cost reports, and recover missed revenue opportunities make R1 a trusted partner in delivering comprehensive solutions that providers seek.
- R1 clients surveyed by KLAS expressed their satisfaction with the company’s Ambulatory RCM Services, with one hospital CEO commenting in October 2023, “R1 is evolving in a challenging and changing healthcare business environment.
Retrieved on:
Wednesday, January 17, 2024
MSD,
BDT,
Hand,
Centerview Partners,
LLP,
RCM,
Adjustment,
Partnership,
Kirkland & Ellis,
McDermott Will & Emery,
Acquisition,
J. P. Morgan,
Internationalized domain name,
Reliability-centered maintenance,
Real estate MURRAY, Utah, Jan. 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has completed its previously announced acquisition of Acclara from Providence, one of the nation's largest health systems. In addition, the Company announced that it expects to release financial results for the fourth quarter and full year ended December 31, 2023, and its 2024 outlook and will host a conference call at 8:00 a.m. ET on Tuesday, February 27, 2024, to discuss the results and business outlook.
Key Points:
- ET on Tuesday, February 27, 2024, to discuss the results and business outlook.
- Upon closing, R1 begins its 10-year partnership with Providence for comprehensive revenue cycle services that leverage the breadth of integrated technology and services capabilities of both R1 and Acclara.
- Centerview Partners LLC and J.P. Morgan acted as financial advisors to R1, and Perkins Coie LLP, Kirkland & Ellis LLP, and Baker Donelson acted as legal counsel.
- BDT & MSD Partners acted as financial advisor to Providence, and McDermott Will & Emery and ArentFox Schiff LLP acted as legal counsel.
